RIPK1 and autoimmune disease: The results showed that there was no significant difference in the expression levels of TRAF6 and RIP1 during the two test periods, indicating that the activation and inhibition of NF-κB signaling pathway belonged to the category of innate immune of bovine mammary gland and did not lead to mastitis and autoimmune diseases of the analyzed cows.